April is Parkinson’s Disease Awareness Month: What Should You Know?, Thursday, April 6th, 2017, 12:00-1:00pm.
This session will look at the value of early diagnosis and specialist treatment of Parkinson’s disease and understand the current limitations on treatment and the need for neuroprotectant therapies.
Joseph Quinn, MD, Professor of Neurology at OHSU, Director of OHSU Parkinson’s Center and Directors of Portland VA Medical Center Parkinson’s Disease Research, Education, and Clinical Care Center (PADRECC), Portland, Oregon.
Dr. Quinn is a neurologist at Oregon Health and Science University and the Portland VA Medical Center, specializing in cognitive disorders and movement disorders. He is director of the OHSU Parkinson’s Center and director of the Northwest VA Parkinson’s Disease Research, Education, and Clinical Care Center (PADRECC). He has also serves as Biomarker Core Director for the Oregon Alzheimer’s Disease Center.
Dr. Quinn spends about 30% of his time on clinical practice and much of the remaining time on research activities. Dr. Quinn's overall research focus is on developing strategies for treating and preventing cognitive decline and dementia in individuals at risk, including patients with Alzheimer’s and Parkinson’s disease. Specific research projects range from animal studies testing experimental treatment strategies, to clinical studies evaluating “biomarkers” and experimental treatments. Currently funded studies include preclinical studies of “re-purposed” drugs and a novel estrogen-like drug, and clinical studies of “microRNAs” as biomarkers, and of nutritional strategies as therapeutic interventions.